Free C-peptide immunoreactivity in insulin-treated diabetics. 1977

H Oyama, and M Horino, and Y Nakashima, and A Tenku, and S Matsumura

UI MeSH Term Description Entries
D007328 Insulin A 51-amino acid pancreatic hormone that plays a major role in the regulation of glucose metabolism, directly by suppressing endogenous glucose production (GLYCOGENOLYSIS; GLUCONEOGENESIS) and indirectly by suppressing GLUCAGON secretion and LIPOLYSIS. Native insulin is a globular protein comprised of a zinc-coordinated hexamer. Each insulin monomer containing two chains, A (21 residues) and B (30 residues), linked by two disulfide bonds. Insulin is used as a drug to control insulin-dependent diabetes mellitus (DIABETES MELLITUS, TYPE 1). Iletin,Insulin A Chain,Insulin B Chain,Insulin, Regular,Novolin,Sodium Insulin,Soluble Insulin,Chain, Insulin B,Insulin, Sodium,Insulin, Soluble,Regular Insulin
D007330 Insulin Antibodies Antibodies specific to INSULIN. Antibodies, Insulin
D010455 Peptides Members of the class of compounds composed of AMINO ACIDS joined together by peptide bonds between adjacent amino acids into linear, branched or cyclical structures. OLIGOPEPTIDES are composed of approximately 2-12 amino acids. Polypeptides are composed of approximately 13 or more amino acids. PROTEINS are considered to be larger versions of peptides that can form into complex structures such as ENZYMES and RECEPTORS. Peptide,Polypeptide,Polypeptides
D002096 C-Peptide The middle segment of proinsulin that is between the N-terminal B-chain and the C-terminal A-chain. It is a pancreatic peptide of about 31 residues, depending on the species. Upon proteolytic cleavage of proinsulin, equimolar INSULIN and C-peptide are released. C-peptide immunoassay has been used to assess pancreatic beta cell function in diabetic patients with circulating insulin antibodies or exogenous insulin. Half-life of C-peptide is 30 min, almost 8 times that of insulin. Proinsulin C-Peptide,C-Peptide, Proinsulin,Connecting Peptide,C Peptide,C Peptide, Proinsulin,Proinsulin C Peptide
D003429 Cross Reactions Serological reactions in which an antiserum against one antigen reacts with a non-identical but closely related antigen. Cross Reaction,Reaction, Cross,Reactions, Cross
D003920 Diabetes Mellitus A heterogeneous group of disorders characterized by HYPERGLYCEMIA and GLUCOSE INTOLERANCE.
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man

Related Publications

H Oyama, and M Horino, and Y Nakashima, and A Tenku, and S Matsumura
January 1977, Diabetes,
H Oyama, and M Horino, and Y Nakashima, and A Tenku, and S Matsumura
July 1980, American journal of clinical pathology,
H Oyama, and M Horino, and Y Nakashima, and A Tenku, and S Matsumura
November 1982, Zhonghua yi xue za zhi,
H Oyama, and M Horino, and Y Nakashima, and A Tenku, and S Matsumura
August 1976, Diabetologia,
H Oyama, and M Horino, and Y Nakashima, and A Tenku, and S Matsumura
January 1987, Diabetes care,
H Oyama, and M Horino, and Y Nakashima, and A Tenku, and S Matsumura
March 1973, Hormone and metabolic research = Hormon- und Stoffwechselforschung = Hormones et metabolisme,
H Oyama, and M Horino, and Y Nakashima, and A Tenku, and S Matsumura
January 1976, Endokrynologia Polska,
H Oyama, and M Horino, and Y Nakashima, and A Tenku, and S Matsumura
January 1995, Revista de investigacion clinica; organo del Hospital de Enfermedades de la Nutricion,
H Oyama, and M Horino, and Y Nakashima, and A Tenku, and S Matsumura
June 1975, Clinical chemistry,
Copied contents to your clipboard!